For: | Akbar SMF, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 2006; 12(18): 2876-2883 [PMID: 16718812 DOI: 10.3748/wjg.v12.i18.2876] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i18/2876.htm |
Number | Citing Articles |
1 |
Mohamed M S Farag, Reda A Suef, Ghada M Al-Toukhy, Mohamed A Selim, Mostafa A Elbahnasawy, Nahla El Sharkawy, Sameera Ezzat, Nashwa Shebl, Mohamed T M Mansour. <p>HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production</p>. Infection and Drug Resistance 2020; : 2699 doi: 10.2147/IDR.S265681
|
2 |
Qiang Li, Furong Lu, Guohong Deng, Kaifa Wang. Modeling the effects of covalently closed circular DNA and dendritic cells in chronic HBV infection. Journal of Theoretical Biology 2014; 357: 1 doi: 10.1016/j.jtbi.2014.04.037
|
3 |
Emilio D'Ugo, Andrea Canitano, Stefania Catone, Roberto Giuseppetti, Loreta A. Kondili, Claudio Argentini, Maria Rapicetta. Effect of an immunogenic complex containing WHV viral particles and non-neutralizing anti-HBs antibodies on the outcome of WHV infection in woodchucks. Journal of Medical Virology 2011; 83(1): 178 doi: 10.1002/jmv.21942
|
4 |
Kai Yang, Shi-He Guan, Hao Zhang, Ying Pan, Yuan-Yuan Wu, Ai-Hua Wang, Bei-Bei Sun. Enhanced Levels of Interleukin-8 Are Associated with Hepatitis B Virus Infection and Resistance to Interferon-Alpha Therapy. International Journal of Molecular Sciences 2014; 15(11): 21286 doi: 10.3390/ijms151121286
|
5 |
Natalia Freitas, Tetyana Lukash, Megan Dudek, Sam Litwin, Stephan Menne, Severin O. Gudima. Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks. Virus Research 2015; 205: 12 doi: 10.1016/j.virusres.2015.05.003
|
6 |
Yuan Hong, Yibing Peng, Michael Mi, Haiyan Xiao, David H. Munn, Gui-qiang Wang, Yukai He. Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice. Vaccine 2011; 29(22): 3909 doi: 10.1016/j.vaccine.2011.03.025
|
7 |
E. S. Cannizzo, C. Tincati, F. Binda, P. Ronzi, F. A. Cazzaniga, S. Antinori, A. d'Arminio Monforte, G. Marchetti, L. Milazzo. Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study. Journal of Viral Hepatitis 2018; 25(4): 381 doi: 10.1111/jvh.12820
|
8 |
Dinesh Mishra, Pradyumna Kumar Mishra, Vaibhav Dubey, Manoj Nahar, Sunil Dabadghao, N.K. Jain. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. European Journal of Pharmaceutical Sciences 2008; 33(4-5): 424 doi: 10.1016/j.ejps.2008.01.015
|
9 |
Shenglan Dai, Xiaohua Chen, Yongsheng Yu, Guoqing Zang, Zhenghao Tang. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9487
|
10 |
Fu-Sheng Wang, Zheng Zhang. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Review of Gastroenterology & Hepatology 2009; 3(5): 499 doi: 10.1586/egh.09.50
|
11 |
Shenglan Dai, Meng Zhuo, Linlin Song, Xiaohua Chen, Yongsheng Yu, Zhenghao Tang, Guoqing Zang. Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responsesin vivo. Acta Biochimica et Biophysica Sinica 2015; 47(11): 870 doi: 10.1093/abbs/gmv093
|
12 |
Mohamed M.S. Farag, Birgit Hoyler, Jens Encke, Wolfgang Stremmel, Kilian Weigand. Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice. Vaccine 2010; 29(2): 200 doi: 10.1016/j.vaccine.2010.10.056
|
13 |
Chao Wu, Yong Liu, Qi Zhao, Guangmei Chen, Junhao Chen, Xiaomin Yan, Yi-Hua Zhou, Zuhu Huang. Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-370
|
14 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Lei Jin, Zhenping Fan, Zheng Zhang, Liming Chen, Huifeng Wang, George K.K. Lau, Fu-Sheng Wang. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology 2009; 132(1): 43 doi: 10.1016/j.clim.2009.03.001
|
15 |
Dawn Tung Au, Jialin Wu, Zhihong Jiang, Hubiao Chen, Guanghua Lu, Zhongzhen Zhao. Ethnobotanical study of medicinal plants used by Hakka in Guangdong, China. Journal of Ethnopharmacology 2008; 117(1): 41 doi: 10.1016/j.jep.2008.01.016
|
16 |
Rémi J. Creusot, Shahriar S. Yaghoubi, Pearl Chang, Justine Chia, Christopher H. Contag, Sanjiv S. Gambhir, C. Garrison Fathman. Lymphoid tissue–specific homing of bone marrow–derived dendritic cells. Blood 2009; 113(26): 6638 doi: 10.1182/blood-2009-02-204321
|
17 |
Suling Li, Alistair L. J. Symonds, Tizong Miao, Ian Sanderson, Ping Wang. Modulation of Antigen-Specific T-Cells as Immune Therapy for Chronic Infectious Diseases and Cancer. Frontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00293
|
18 |
Ming Shi, Junliang Fu, Feng Shi, Bin Zhang, Zirong Tang, Zheng Zhang, Hui Zhang, Lei Jin, Liming Chen, Huifeng Wang, Sheikh Mohammad Fazle Akbar, Fu-Sheng Wang. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion. Liver International 2009; 29(3): 466 doi: 10.1111/j.1478-3231.2008.01861.x
|
19 |
Dinesh Mishra, Pradyumna Kumar Mishra, Sunil Dabadghao, Vaibhav Dubey, Manoj Nahar, Narendra K. Jain. Comparative evaluation of hepatitis B surface antigen–loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomedicine: Nanotechnology, Biology and Medicine 2010; 6(1): 110 doi: 10.1016/j.nano.2009.04.003
|
20 |
Emilio D'Ugo, Claudio Argentini, Roberto Giuseppetti, Andrea Canitano, Stefania Catone, Maria Rapicetta. The woodchuck hepatitis B virus infection model for the evaluation of HBV therapies and vaccine therapies. Expert Opinion on Drug Discovery 2010; 5(12): 1153 doi: 10.1517/17460441.2010.530252
|
21 |
Yasuteru Kondo, Yoshiyuki Ueno, Tooru Shimosegawa. Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies. Clinical Journal of Gastroenterology 2009; 2(2): 71 doi: 10.1007/s12328-009-0074-z
|
22 |
Liangen Chen, Zheng Zhang, Weiwei Chen, Zhidong Zhang, Yonggang Li, Ming Shi, Jiyuan Zhang, Lieping Chen, Shengdian Wang, Fu-Sheng Wang. B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis B. The Journal of Immunology 2007; 178(10): 6634 doi: 10.4049/jimmunol.178.10.6634
|
23 |
P. Zhou, J. Xu, M. Dai, Y. Shi, G. Wu, Y. Fang, X. Yan. The immunosuppressive effects of CD4+
CD25+
regulatory T cells on dendritic cells in patients with chronic hepatitis B. Journal of Viral Hepatitis 2018; 25(6): 733 doi: 10.1111/jvh.12863
|
24 |
Fu-Sheng Wang. Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges. Hepatology Research 2007; 37(s3): S339 doi: 10.1111/j.1872-034X.2007.00222.x
|